Stocks/CRMD

Create a free account to see ACCE Scores

Sign up for free to unlock scores, score breakdowns, and stock analysis.

CRMD

↓ PDF (Pro)
CorMedix Inc. Common Stock
HealthcareBiotechnologyUnited StatesNASDAQ
$7.75
-1.96%today
MKT CAP
$632M
+6.0% · 1Y
Earnings History
+22.4%
+49.6%
+121.7%
-80.2%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$7.75
Low
$13.00
Analyst Mean
$15.00
High
$19.00
7 analystsStrong Buy
Full Financials
Trailing P/E3.8x
Forward P/E10.8x
EV/EBITDA3.6x
Price/Sales-
Dividend Yield-
Revenue Growth YoY+312.1%
Earnings Growth YoY-28.3%
Revenue Growth QoQ+23.3%
5y Revenue CAGR+1582.8%
5y Earnings CAGR-
Gross Margin92.9%
Operating Margin53.9%
Net Margin52.3%
ROE66.6%
Debt / Equity36.74x
Free Cash Flow$109M
Insider Ownership7.5%
Institutional Ownership56.3%
Short % of Float20.31%
Days to Cover13.3d
1 Week+2.1%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
FilerRoleTypeSharesPriceValueDate
TODISCO JOSEPHChief Executive OfficerStock77,156$0.00$0.00M2026-02-04
ZELNICK KAUFMAN BETHOfficerStock36,006$0.00$0.00M2026-02-04
HURLBURT ELIZABETHChief Operating OfficerStock36,006$0.00$0.00M2026-02-04
LEFKOWITZ STEVEN WDirectorStock30,453$0.00$0.00M2026-01-26
DUNTON ALAN WILLIAMDirectorStock30,453$0.00$0.00M2026-01-26
Top Holders
HolderType% HeldValueΔ SharesAs of
Blackrock Inc.institution7.36%$0.05B+1.55%2025-12-31
Deep Track Capital, Lpinstitution6.72%$0.04B+954.82%2025-12-31
Vanguard Group Incinstitution5.74%$0.04B+13.11%2025-12-31
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fundfund2.84%$0.02B+14.48%2025-12-31
Marshall Wace LLPinstitution2.51%$0.02B-43.39%2025-12-31
State Street Corporationinstitution2.45%$0.02B+4.64%2025-12-31
Geode Capital Management, LLCinstitution2.44%$0.02B+5.66%2025-12-31
iShares Trust-iShares Russell 2000 ETFfund2.34%$0.01B+0.68%2026-03-31
UBS Group AGinstitution1.96%$0.01B+141.85%2026-03-31
Deerfield Management Company, L.Pinstitution1.41%$0.01B-66.67%2025-12-31
Alyeska Investment Group, L.p.institution1.08%$0.01B-32.70%2025-12-31
Goldman Sachs Group Incinstitution1.06%$0.01B+259.07%2025-12-31
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fundfund1.01%$0.01B+5.18%2025-12-31
OBERWEIS FUNDS-Oberweis Micro-Cap Fundfund1.00%$0.01B+0.00%2025-12-31
Fidelity Salem Street Trust-Fidelity Small Cap Index Fundfund0.93%$0.01B+1.06%2026-02-28
iShares Trust-iShares Russell 2000 Growth ETFfund0.78%$0.00B-1.15%2026-03-31
SPDR SERIES TRUST-State Street SPDR S&P Pharmaceuticals ETFfund0.71%$0.00B+19.22%2026-03-31
World Funds Trust-Applied Finance Explorer Fundfund0.69%$0.00B+100.00%2026-01-31
Fidelity Concord Street Trust-Fidelity Extended Market Index Fundfund0.49%$0.00B+1.96%2026-02-28
VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fundfund0.47%$0.00B+6.53%2026-02-28
TickerCapScoreP/EFwd P/EEV/EBITDAROEGrossD/EDiv
PTGX
Protagonist Therapeutics Inc. Common Stock
$6.6B5------0.00%
CELC
Celcuity Inc. Common Stock
$6.7B5------0.00%
ACLX
Arcellx Inc. Common Stock
$6.7B5-------
KYMR
Kymera Therapeutics Inc. Common Stock
$7.0B-----27.1%0%5.230.00%
TECH
Bio-Techne Corp Common Stock
$7.1B3672.724.4----63.00%
HALO
Halozyme Therapeutics Inc. Common Stock
$7.9B7325.56.6----0.00%
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Upgrade from $15/mo →
Growth73Value58Quality82Momentum61Total89
Score breakdown on Starter+
Upgrade →
Score History (90d)
Pro onlyUpgrade →
Updated 5/8/2026
Recent Alerts
No alerts yet for CRMD.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →
Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.